Cellares vs Oryon Cell Therapies
Cellares vs Oryon Cell Therapies, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cellares is on 54/100 and Oryon Cell Therapies on 62/100.
Where each one leads
Cellares
- agent readiness: 42/100 against 22/100
- funding raised: $327M against $21.0M
Oryon Cell Therapies
- our overall score: 62/100 against 54/100
At a glance
| Measure | Cellares | Oryon Cell Therapies |
|---|---|---|
| What it is | The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies. | Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Life Sciences | Biotechnology, Health, Neuroscience, Cell Therapy |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2019 | Not published |
| Headquarters | South San Francisco, USA | Belmont, USA |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Cellares | Oryon Cell Therapies |
|---|---|---|
| Total funding | $327M | $21.0M |
| Latest round | Funding Round | Series A |
| Valuation | $1.1B | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cellares | Oryon Cell Therapies |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 54/100 | 62/100 |
| Traction | 40/100 | 38/100 |
| Search visibility | 15/100 | 19/100 |
| Quality | 78/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 43/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cellares | Oryon Cell Therapies |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Not detected |
| Support stack | HubSpot | Not detected |
What users say
| Measure | Cellares | Oryon Cell Therapies |
|---|---|---|
| Reddit sentimentThreads we track | 2 positive, 0 negative across 4 threads | Not published |
“Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel.”r/CABAinvest
Cellares vs Oryon Cell Therapies: common questions
Which is better, Cellares or Oryon Cell Therapies?
On our 0-100 score Oryon Cell Therapies rates higher (62/100 against 54/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.
How do Cellares and Oryon Cell Therapies compare on the numbers?
Cellares leads on agent readiness (42/100 against 22/100), funding raised ($327M against $21.0M). Oryon Cell Therapies leads on our overall score (62/100 against 54/100).
What do real users say about Cellares and Oryon Cell Therapies?
Cellares: 2 positive and 0 negative mentions across 4 Reddit threads we track, mostly in r/CABAinvest.
Read the full Cellares review and pricing or the Oryon Cell Therapies review and pricing. You can also browse other Cellares alternatives we track.